门诊使用白细胞介素-2和干扰素能否替代高剂量白细胞介素-2治疗转移性肾细胞癌？ - Suppr

Suppr

超能文献

Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?

作者信息

Vieweg Johannes

机构信息

Department of Urology, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Nat Clin Pract Oncol. 2005 Apr;2(4):192-3. doi: 10.1038/ncponc0134.

DOI:10.1038/ncponc0134

PMID:16264932

Abstract

摘要

相似文献

Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?

Nat Clin Pract Oncol. 2005 Apr;2(4):192-3. doi: 10.1038/ncponc0134.

Aldesleukin for metastatic renal cell carcinoma?

Drug Ther Bull. 1993 Apr 13;31(8):29-30.

Immunotherapy in metastatic renal cell carcinoma.

World J Urol. 2005 Jul;23(3):196-201. doi: 10.1007/s00345-004-0470-4. Epub 2005 Apr 2.

Cytokine therapy for metastatic renal cell carcinoma.

Semin Urol Oncol. 2001 May;19(2):148-54.

Of snails and holy grails..

Cancer J Sci Am. 1997 May-Jun;3(3):142-3.

Cytokine therapy: a standard of care for metastatic renal cell carcinoma?

Clin Genitourin Cancer. 2005 Dec;4(3):181-6. doi: 10.3816/CGC.2005.n.030.

Predicting survival of patients with metastatic renal cell carcinoma.

Urologe A. 2004 Sep;43 Suppl 3:S135-6. doi: 10.1007/s00120-004-0602-x.

Maintenance biotherapy with interleukin-2 and interferon for metastatic renal cell cancer.

Expert Rev Anticancer Ther. 2006 Jan;6(1):141-52. doi: 10.1586/14737140.6.1.141.

Modest effect of interferon alfa on metastatic renal-cell carcinoma.

Lancet. 1999 Jan 2;353(9146):6-7. doi: 10.1016/S0140-6736(05)74876-5.

[Cytokine therapy for metastatic renal cell carcinoma].

Gan To Kagaku Ryoho. 2002 Oct;29(10):1738-44.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?

Nat Clin Pract Oncol. 2005 Apr;2(4):192-3. doi: 10.1038/ncponc0134.

Aldesleukin for metastatic renal cell carcinoma?

Drug Ther Bull. 1993 Apr 13;31(8):29-30.

Immunotherapy in metastatic renal cell carcinoma.

World J Urol. 2005 Jul;23(3):196-201. doi: 10.1007/s00345-004-0470-4. Epub 2005 Apr 2.

Cytokine therapy for metastatic renal cell carcinoma.

Semin Urol Oncol. 2001 May;19(2):148-54.

Of snails and holy grails..

Cancer J Sci Am. 1997 May-Jun;3(3):142-3.

Cytokine therapy: a standard of care for metastatic renal cell carcinoma?

Clin Genitourin Cancer. 2005 Dec;4(3):181-6. doi: 10.3816/CGC.2005.n.030.

Predicting survival of patients with metastatic renal cell carcinoma.

Urologe A. 2004 Sep;43 Suppl 3:S135-6. doi: 10.1007/s00120-004-0602-x.

Maintenance biotherapy with interleukin-2 and interferon for metastatic renal cell cancer.

Expert Rev Anticancer Ther. 2006 Jan;6(1):141-52. doi: 10.1586/14737140.6.1.141.

Modest effect of interferon alfa on metastatic renal-cell carcinoma.

Lancet. 1999 Jan 2;353(9146):6-7. doi: 10.1016/S0140-6736(05)74876-5.

[Cytokine therapy for metastatic renal cell carcinoma].

Gan To Kagaku Ryoho. 2002 Oct;29(10):1738-44.